BEUT: AI 评分 48/100 — AI 分析 (4月 2026)

Science to Consumers, Inc. is a development stage company focused on marketing anti-aging cream and distributing Argan oil products. The company targets individual and commercial customers, including spas and stores.

Key Facts: AI Score: 48/100 Sector: Consumer Defensive

公司概况

概要：

Science to Consumers, Inc., operating in the consumer defensive sector, is a development stage company focused on marketing anti-aging cream under the DermaLastyl name and distributing Argan oil. Targeting both individual and commercial customers, the company faces challenges common to early-stage businesses in a competitive market.

BEUT是做什么的？

Science to Consumers, Inc., founded in 2013 and based in Guangzhou, China, is a development stage company operating within the household and personal products industry. Initially named Argan Beauty Corporation, the company rebranded in December 2014 to reflect its broader focus on scientific approaches to consumer products. The company's primary activities revolve around the marketing and sale of formulated anti-aging cream products under the DermaLastyl brand and the distribution of Argan oil products. Science to Consumers, Inc. targets a dual customer base, aiming to reach both individual consumers and commercial entities such as spas, stores, and massage therapy offices. This strategy is intended to diversify its revenue streams and establish a presence in various market segments. As a development stage company, Science to Consumers, Inc. is likely focused on establishing its brand, refining its product offerings, and building its distribution network. The company's success will depend on its ability to effectively market its products, manage its supply chain, and compete with established players in the anti-aging and personal care markets. The company currently has one employee.

BEUT的投资论点是什么？

Science to Consumers, Inc. presents a high-risk, high-reward investment profile typical of development stage companies. With a market capitalization of $0.00B and a negative P/E ratio of -0.05, the company's financial performance is currently not indicative of profitability. Key value drivers include successful product marketing and distribution, particularly for its DermaLastyl anti-aging cream. Growth catalysts hinge on securing commercial customer contracts and expanding its online presence. However, potential risks include intense competition in the personal care market, limited financial resources, and the challenges of scaling operations. Investors should closely monitor the company's ability to generate revenue and manage its expenses.

BEUT在哪个行业运营？

Science to Consumers, Inc. operates in the competitive household and personal products industry, which is characterized by established multinational corporations and emerging niche brands. The anti-aging segment, in particular, is driven by consumer demand for innovative and effective products. The company faces competition from major players like ESINQ, EVKG, GPDB, MDAV, and PCGR. Success in this market requires strong branding, effective distribution channels, and continuous product innovation to meet evolving consumer preferences. The industry is also influenced by trends such as natural and organic ingredients, personalized skincare, and e-commerce growth.

Household & Personal Products

Consumer Defensive

BEUT有哪些增长机遇？

Expansion into E-commerce Channels: Science to Consumers, Inc. can leverage the growing e-commerce market to reach a broader customer base. By establishing a strong online presence through its own website and partnerships with online retailers, the company can overcome geographical limitations and tap into the global demand for anti-aging and personal care products. The global e-commerce market is projected to reach trillions of dollars by 2026, offering significant growth potential.
Strategic Partnerships with Spas and Salons: Collaborating with spas, salons, and massage therapy offices can provide Science to Consumers, Inc. with a valuable distribution channel and enhance brand visibility. By offering exclusive product packages and training programs, the company can incentivize these businesses to promote and sell its DermaLastyl cream and Argan oil products. This approach can also generate recurring revenue and foster customer loyalty.
Product Line Expansion: Science to Consumers, Inc. can diversify its product portfolio by introducing complementary skincare and personal care items. This could include cleansers, toners, moisturizers, and other products that complement its existing anti-aging cream and Argan oil offerings. By expanding its product line, the company can cater to a wider range of customer needs and increase its revenue potential. The global skincare market is projected to reach hundreds of billions of dollars by 2026.
Targeted Marketing Campaigns: Implementing targeted marketing campaigns focused on specific demographics and customer segments can improve brand awareness and drive sales. By leveraging social media, search engine optimization, and influencer marketing, the company can reach potential customers who are actively seeking anti-aging and personal care solutions. Effective marketing campaigns can also highlight the unique benefits of its DermaLastyl cream and Argan oil products.
International Market Expansion: Science to Consumers, Inc. can explore opportunities to expand its operations into international markets, particularly in regions with a growing demand for anti-aging and personal care products. By adapting its products and marketing strategies to suit local preferences and regulations, the company can tap into new revenue streams and diversify its geographic risk. The global anti-aging market is expected to grow significantly in the coming years, offering substantial opportunities for international expansion.

Market capitalization of $0.00B indicates a micro-cap company with limited resources.
P/E ratio of -0.05 reflects the company's current lack of profitability.
Beta of 0.11 suggests the stock is less volatile than the overall market.
The company focuses on the anti-aging cream and Argan oil product markets.
The company targets both individual and commercial customers, such as spas and stores.

BEUT提供哪些产品和服务？

Markets and sells anti-aging cream products under the DermaLastyl name.
Distributes Argan oil products.
Targets individual customers seeking anti-aging solutions.
Aims to sell to commercial customers like spas and stores.
Focuses on formulating and distributing skincare products.
Operates as a development stage company.

BEUT如何赚钱？

Sells anti-aging cream products directly to consumers.
Distributes Argan oil through various channels.
Targets commercial customers for bulk sales and distribution agreements.

Individual consumers seeking anti-aging skincare solutions.
Spas and salons offering skincare treatments.
Retail stores selling personal care products.
Massage therapy offices using Argan oil.

Proprietary DermaLastyl anti-aging cream formulation.
Established distribution channels with spas and stores.
Brand recognition in the anti-aging skincare market.
First-mover advantage in specific niche markets.

什么因素可能推动BEUT股价上涨？

Upcoming: Launch of new marketing campaigns to promote DermaLastyl cream.
Upcoming: Potential partnerships with spas and salons for product distribution.
Ongoing: Expansion of online sales channels through e-commerce platforms.
Ongoing: Development of new skincare products to complement existing offerings.
Ongoing: Exploration of international market opportunities for product expansion.

BEUT的主要风险是什么？

Potential: Intense competition from established players in the personal care market.
Potential: Limited financial resources to support marketing and product development.
Potential: Changing consumer preferences and trends in the skincare industry.
Ongoing: Dependence on a small product line and limited customer base.
Ongoing: Regulatory compliance and potential legal challenges.

BEUT的核心优势是什么？

Proprietary DermaLastyl anti-aging cream formulation.
Targeting both individual and commercial customers.
Distribution of Argan oil products.
Focus on a growing anti-aging market.

BEUT的劣势是什么？

Development stage company with limited resources.
Dependence on a small product line.
Limited brand recognition.
Single employee.

BEUT有哪些机遇？

Expansion into e-commerce channels.
Strategic partnerships with spas and salons.
Product line expansion with complementary skincare items.
International market expansion.

BEUT面临哪些威胁？

Intense competition in the personal care market.
Changing consumer preferences and trends.
Regulatory requirements and compliance.
Economic downturn affecting consumer spending.

BEUT的竞争对手是谁？

Elixinol Wellness Global Limited — Focuses on hemp-derived products. — (ESINQ)
Eve Holding, Inc. — Operates in the electric vertical takeoff and landing (eVTOL) market. — (EVKG)
GPDB Holdings, Inc. — Unknown differentiation. — (GPDB)
MedAvail Holdings, Inc. — Focuses on pharmacy services and technology. — (MDAV)
The Procter & Gamble Company — A multinational consumer goods corporation. — (PCGR)

Key Metrics

MoonshotScore: 48/100

Company Profile

CEO: Ensley Edwon Lam
Headquarters: Guangzhou, CN
Employees: 1
Founded: 2014

AI Insight

AI analysis pending for BEUT

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Science to Consumers, Inc. do?

Science to Consumers, Inc. is a development stage company that focuses on the formulation, marketing, and sale of anti-aging cream products under the DermaLastyl brand, as well as the distribution of Argan oil. The company targets both individual consumers seeking skincare solutions and commercial customers like spas, salons, and retail stores. Operating in the consumer defensive sector, Science to Consumers, Inc. aims to establish a presence in the competitive household and personal products market by offering specialized skincare products.

What do analysts say about BEUT stock?

As a development stage company trading on the OTC market, Science to Consumers, Inc. (BEUT) currently lacks analyst coverage. Key valuation metrics such as revenue growth, profitability, and cash flow are limited or unavailable. Investors should conduct their own thorough due diligence and consider the risks associated with investing in micro-cap companies with limited financial disclosure. The company's future performance will depend on its ability to execute its business plan and generate revenue.

What are the main risks for BEUT?

Science to Consumers, Inc. faces several key risks, including intense competition in the personal care market, limited financial resources, and dependence on a small product line. As a development stage company, it also faces execution risks related to product development, marketing, and distribution. The company's OTC listing adds further risks related to liquidity, transparency, and regulatory oversight. Investors should carefully consider these risks before investing in BEUT.